🇪🇺 Seasonal influenza vaccine in European Union

EMA authorised Seasonal influenza vaccine on 24 February 2009

Marketing authorisation

EMA — authorised 24 February 2009

  • Application: EMEA/H/C/000957
  • Marketing authorisation holder: Sanofi Pasteur Europe
  • Local brand name: Intanza
  • Indication: Prophylaxis of influenza in individuals 60 years of age and over, especially in those who run an increased risk of associated complications.The use of Intanza should be based on official recommendations.
  • Status: withdrawn

Read official source →

Other Immunology approved in European Union

Frequently asked questions

Is Seasonal influenza vaccine approved in European Union?

Yes. EMA authorised it on 24 February 2009.

Who is the marketing authorisation holder for Seasonal influenza vaccine in European Union?

Sanofi Pasteur Europe holds the EU marketing authorisation.